Biomea Fusion Inc

Stock Chart, Company Information, and Scan Results

$1.59(as of Aug 24, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Biomea Fusion Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$1.59
Ticker SymbolBMEA
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees37
CountyUSA
Market Cap$99.3M
EBIDTA-55.3M
10-Day Moving Average1.36
P/E Ratio0.00
20-Day Moving Average1.30
Forward P/E Ratio0.00
50-Day Moving Average1.29
Earnings per Share-0.18
200-Day Moving Average1.35
Profit Margin0.00%
RSI77.46
Shares Outstanding72.5M
ATR0.10
52-Week High2.99
Volume11,380,320
52-Week Low0.87
Most Recent Support Level1.31
Book Value0.0M
Most Recent Resistance Level1.32
P/B Ratio0.00
Upper Keltner1.51
P/S Ratio0.00
Lower Keltner1.08
Debt-to-Equity Ratio0.00
Next Earnings DateUnknown
Cash Surplus0.0M
Next Ex-Dividend DateUnknown

Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral drugs to treat patients with diabetes and obesity. It's lead clinical program's drug candidates are COVALENT-111 and COVALENT-112, which has completed Phase II clinical trials of icovamenib for the treatment of Type 1 and Type 2 diabetes; COVALENT-211, which is in Phase II clinical trial of icovamenib for treating insulin-deficient type 2 diabetes; and COVALENT-212, which is in Phase II clinical trial of icovamenib for the treatment of type 2 diabetes. The company is also developing BMF-650, which is in Phase I glucagon-like peptide-131 clinical trial for the treatment of obesity. The company was incorporated in 2017 and is headquartered in San Carlos, California.

Biomea Fusion Inc In Our Stock Scanner

As of Aug 24, 2026
example chart graphic
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Undervalued Blue ChipsScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.